General Research
Model: human
Hydrogen Gas Inhalation Alleviates Radiation-Induced Bone Marrow Damage in Cancer Patients
Simplified Version Available
New Hope for Cancer Patients: How Hydrogen Gas Inhalation Can Reduce Radiation Damage
A recent study from Japan found that inhaling hydrogen gas can help reduce radiation-induced bone marrow damage in cancer patients. Hydrogen gas has antioxidant properties that selectively target and neutralize harmful free radicals produced during radiation therapy. This breakthrough could lead to new ways to reduce the side effects of radiation therapy and improve treatment outcomes for cancer patients.
Read Simplified ArticleAbstract
Publish Year 2019 Country Japan Rank Positive Journal SSRN Electronic Journal Primary Topic Bone Marrow Secondary TopicCancer Model Human Tertiary TopicRadioprotection Vehicle Gas pH N/A Application Inhalation Comparison Complement Radiotherapy for cancer patients is one of the useful methods; however, it not only impairs the targeted tumor tissues but also damage the normal surrounding tissues. Intensity modulated radiation therapy (IMRT) for cancer patients has been recently performed to alleviate the adverse effects, but reducing bone marrow damage is limited in the patients with multiple tumor lesions and large irradiation volume. Molecular hydrogen (H2) was recently reported as a preventive and therapeutic antioxidant that selectively scavenges hydroxy radical (*OH) and peroxynitrite (ONOO-). This observational study aims to examine whether H2 gas treatment improves IMRT radiation-induced bone marrow damage in cancer patients. Methods: